Chemotherapy

FILE - In this May 5, 2019, file photo Alex Trebek poses in the press room at the 46th annual Daytime Emmy Awards at the Pasadena Civic Center in Pasadena, Calif. Trebek said Tuesday, Sept. 17, that he’s had a setback in his battle with pancreatic cancer and is undergoing chemotherapy again.(Photo by Richard Shotwell/Invision/AP, File)
September 17, 2019 - 12:42 pm
NEW YORK (AP) — "Jeopardy!" host Alex Trebek says he's had a setback in his battle with pancreatic cancer and is undergoing chemotherapy again. Trebek told ABC's "Good Morning America" on Tuesday that after a short period of optimism when he stopped chemotherapy, his "numbers shot up" and doctors...
Read More
Cancer patient Kim Lauerman poses for a portrait in her home Wednesday, June 26, 2019, in Alpharetta, Ga. After Lauerman was diagnosed with ovarian cancer, doctors wanted to give her a drug that helps prevent infections and fever during chemotherapy. Her insurer said no. Doctors say they worry about the growing influence insurers have over patient care. They say treatment delays and the problems they create are becoming common because routine things like imaging exams or prescriptions now require insurer approval first. (AP Photo/John Bazemore)
July 29, 2019 - 11:01 am
After Kim Lauerman was diagnosed with ovarian cancer, doctors wanted to give her a drug that helps prevent infections and fever during chemotherapy. Her insurer said no. Anthem Blue Cross told Lauerman the drug wasn't necessary. She eventually got it after an infection landed her in the hospital,...
Read More
June 03, 2019 - 2:12 pm
CHICAGO (AP) — Newer drugs are substantially improving the chances of survival for some people with hard-to-treat forms of lung, breast and prostate cancer, doctors reported at the world's largest cancer conference. Among those who have benefited is Roszell Mack Jr., who at age 87 is still able to...
Read More
FILE - This Oct. 14, 2015 file photo shows the Food & Drug Administration campus in Silver Spring, Md. On Friday, March 8, 2019, the FDA approved Roche’s Tecentriq, the first cancer immunotherapy for treating an aggressive type of breast cancer. (AP Photo/Andrew Harnik, File)
March 08, 2019 - 3:26 pm
The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer. Swiss drugmaker Roche's Tecentriq was OK'd Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It's to be given with chemotherapy, the standard...
Read More
FILE - This undated fluorescence-colored microscope image made available by the National Institutes of Health in September 2016 shows a culture of human breast cancer cells. For the first time, one of the new immunotherapy drugs has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease. Results were discussed Saturday, Oct. 20, 2018 at a European Society for Medical Oncology conference in Munich and published by the New England Journal of Medicine. (Ewa Krawczyk/National Cancer Institute via AP)
October 20, 2018 - 1:43 pm
For the first time, one of the new immunotherapy drugs has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease. But the benefit for most women was small, raising questions about whether the treatment is worth its high...
Read More
New York Giants general manager Dave Gettleman speaks with reporters at NFL football training camp, Friday, July 27, 2018, in East Rutherford, N.J. Gettleman said the aggressive cancer he was diagnosed with five weeks ago is in remission. (AP Photo/Tom Canavan)
July 27, 2018 - 3:45 pm
EAST RUTHERFORD, N.J. (AP) — New York Giants general manager Dave Gettleman says the aggressive cancer he was diagnosed with last month is in remission. Speaking to the media for the first time since the Giants disclosed in early June that he had lymphoma, Gettleman said Friday he's had four rounds...
Read More